Aileron Therapeutics, Inc.ALRNNASDAQ
LOADING
|||
| Metric | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 |
|---|---|---|---|---|---|
| Revenue Growth | +0.00% | -5.97% | +0.00% | +0.00% | +0.00% |
| Gross Profit Growth | +0.00% | -23.17% | +0.00% | +0.00% | +0.00% |
| EBITDA Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Operating Income Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Net Income Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| EPS Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| EPS Diluted Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Weighted Average Shares Growth | +377.04% | +315.16% | +163.99% | -99.88% | +21.69% |
| Weighted Average Shares Diluted Growth | +377.04% | +315.16% | +163.99% | -99.88% | +21.69% |
| Dividends per Share Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Operating Cash Flow Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Free Cash Flow Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Receivables Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Inventory Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Asset Growth | +712.80% | -47.86% | -41.90% | -47.46% | -48.47% |
| Book Value per Share Growth | -5.97% | +90.23% | -79.31% | +39026.26% | -24.43% |
| Debt Growth | +0.00% | -100.00% | +0.00% | +0.00% | +0.00% |
| R&D Expense Growth | +16818.18% | +68.46% | -11.81% | +14.73% | -54.84% |
| SG&A Expenses Growth | +20.15% | -53.11% | -31.72% | -51.32% | +62.24% |